Back to list

Prescription only

Alipratinib

Generic Name
Pralsetinib
Specification
100mg × 60 ແຄບຊູນ
Dosage Form
—
FDD Registration No.
05 L 1102/24
Valid until
2028-02-13

Prescription only — Information only — no online sales

Description

Ingredients
Pralsetinib 100mg
Indications
RET fusion-positive non-small cell lung cancer, medullary and papillary thyroid cancer
Dosage & Administration
Oral administration
Description
Alipratinib, active ingredient Pralsetinib, capsule, registered in Lao PDR.

Related products

Aliivosidenib
Prescription only

Aliivosidenib

Generic Name:Ivosidenib

Specification:250mg × 60 ເມັດ

Oncology & Hematology

View Details
ALIOLAPARIB
Prescription only

ALIOLAPARIB

Generic Name:Olaparib

Specification:150mg × 120 ເມັດ

Oncology & Hematology

View Details
Osimitib
Prescription only

Osimitib

Generic Name:Osimertinib

Specification:80mg × 30 ເມັດ

Oncology & Hematology

View Details
ALIDABRAFENIB
Prescription only

ALIDABRAFENIB

Generic Name:Dabrafenib

Specification:75mg × 120 ແຄບຊູນ

Oncology & Hematology

View Details
Information only — no online salesDisclaimer & Terms02057111655

Information only — no online sales · Disclaimer & Terms